| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |